Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Thereby, the goal of our current work is to figure out the functional role of mitochondrial fragmentation in TNF-α-induced septic cardiomyopathy.
|
30740674 |
2019 |
Cardiomyopathies
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Several features were evaluated, including the characterization of T. cruzi directly from the blood of patients, host polymorphisms of genes related to cardiomyopathy (TNF, WISP1, CCR5, and TGF-β1) and clinical aspects of the patients.
|
29922960 |
2018 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
In this review, we explore the emerging role of tumor necrosis factor receptor-associated factor 6 (TRAF6)-nuclear factor kappa B (NF-κB) signaling axis in atherosclerosis, ischemic heart disease, pathologic cardiac hypertrophy or heart failure, myocarditis, and sepsis-induced cardiomyopathy.
|
29175266 |
2018 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Several cytokines including TNF-α, TGF-β, and different interleukins such as IL-1 IL-4, IL-6, IL-8, and IL-18 are involved in the development of various inflammatory cardiac pathologies, namely ischemic heart disease, myocardial infarction, heart failure, and cardiomyopathies.
|
29862462 |
2018 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
The effect of 28 days of celecoxib (100 mg/kg/day) and its combination with folic acid (10 mg/kg/day) was studied on doxorubicin-induced cardiomyopathy according to serum lactate dehydrogenase (LDH), creatine kinase (CK-MB), troponin-T (Tn-T), tumor necrosis factor alpha (TNF-α), cardiac thiobarbituric acid reactive substance (TBARS), and glutathione (GSH) levels as well as systolic blood pressure (SBP), heart rate (HR) and ultrastructural studies.
|
28274156 |
2017 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Here, particular attention has been paid to tumor necrosis factor alpha (TNF) and transforming growth factor beta (TGF-β) although other cytokines may be involved in the chagasic cardiomyopathy.
|
27622432 |
2017 |
Cardiomyopathies
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Bones, tumors, and cardiomyopathy are examples of niches and conditions that contain MSCs and are enriched with tumor necrosis factor α (TNFα) and transforming growth factor β1 (TGFβ1).
|
28553282 |
2017 |
Cardiomyopathies
|
0.600 |
Therapeutic
|
group |
RGD |
Antioxidants and tumor necrosis factor alpha-inhibiting activity of sesame oil against doxorubicin-induced cardiotoxicity.
|
24441175 |
2014 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Tumor necrosis factor (TNF) is an inflammatory cytokine that is upregulated in a number of cardiomyopathies.
|
20007453 |
2010 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
This biological framework, which is also involved in progression of cardiomyopathy in humans, is more pronounced in HIV-infected patients, in whom proinflammatory cytokines TNF-alpha, IL-1 and IL-6 are increased, resulting in an enhanced expression of cardiac iNOS, especially in patients with a low CD4 T cell count.
|
17336407 |
2007 |
Cardiomyopathies
|
0.600 |
GeneticVariation
|
group |
BEFREE |
These results indicate that TNF polymorphisms are associated neither to CCC development nor to progression to more severe forms of cardiomyopathy in Brazilian Chagas disease patients.
|
17141882 |
2007 |
Cardiomyopathies
|
0.600 |
GeneticVariation
|
group |
BEFREE |
TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients.
|
16427798 |
2006 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
|
17038643 |
2006 |
Cardiomyopathies
|
0.600 |
GeneticVariation
|
group |
BEFREE |
We describe a 9-year-old African American boy with the P46L mutation of the TNF receptor who presented with 2 previously unrecognized manifestations: sacroiliitis and myocardiopathy, both showing a reversible course.
|
15630744 |
2005 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Proinflammatory cytokines, including tumor necrosis factor (TNF)alpha, have been recognized as important physiopathogenetic factors in the initiation and continuation of inflammatory cardiomyopathies.
|
15218506 |
2004 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
CTD_human |
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1.
|
10716473 |
2000 |
Cardiomyopathies
|
0.600 |
AlteredExpression
|
group |
BEFREE |
Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression.
|
10953034 |
2000 |
Cardiomyopathies
|
0.600 |
Biomarker
|
group |
BEFREE |
Tumor necrosis factor-alpha (TNF-alpha) is a multifunctional cytokine that has been detected in several human cardiac-related conditions, including congestive heart failure and septic cardiomyopathy.
|
9577949 |
1998 |